MedPath

Lodosyn

LODOSYN (carbidopa) Tablets

Approved
Approval ID

ff8e105b-7415-42d4-bbb2-b36cfb8945a5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2020

Manufacturers
FDA

Bausch Health US, LLC

DUNS: 831922468

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

carbidopa

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code25010-711
Application NumberNDA017830
Product Classification
M
Marketing Category
C73594
G
Generic Name
carbidopa
Product Specifications
Route of AdministrationORAL
Effective DateJuly 1, 2020
FDA Product Classification

INGREDIENTS (5)

carbidopaActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
powdered celluloseInactive
Code: SMD1X3XO9M
Classification: IACT
FD&C Yellow No. 6Inactive
Code: H77VEI93A8
Classification: IACT
starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lodosyn - FDA Drug Approval Details